NASDAQ:ABEO

Abeona Therapeutics Stock Predictions

etoro logo Buy ABEO
*Your capital is at risk
$5.67
-0.0200 (-0.351%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ABEO Prediction Chart

ABEO Predictions History

Latest community submissions for ABEO.
Predictor Target Session Target Price Result Direction Accuracy Score
May 7, 2025 $5.96 +3.47% $5.27 X 86.80% 0
May 7, 2025 $5.88 +2.14% $5.27 X 88.26% 0
May 7, 2025 Bullish $5.27 X 0
May 5, 2025 $6.36 -3.11% $6.40 V 99.32% 4
May 5, 2025 $6.43 -1.94% $6.40 V 99.49% 4
May 5, 2025 Bullish $6.40 X 0
May 5, 2025 $7.55 +15.09% $6.40 X 82.03% 0
May 2, 2025 Bullish $6.56 X 0
May 1, 2025 Bullish $6.87 V 1
Apr 30, 2025 $5.45 +2.85% $6.56 V 83.10% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABEO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE